期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Anlotinib in combination with pembrolizumab for low-grade myofibroblastic sarcoma of the pancreas: A case report
1
作者 Rong-Ting Wu Ji-Cheng Zhang +4 位作者 Cheng-Nan Fang Xiao-Yu Qi Jin-Fei Qiao Ping Li Li Su 《World Journal of Clinical Cases》 SCIE 2023年第35期8385-8391,共7页
BACKGROUND Low-grade myofibroblastic sarcoma(LGMS)is a rare spindle cell sarcoma espe-cially in the pancreas,with myofibroblastic differentiation.Hitherto,only a few cases have been reported.CASE SUMMARY Herein,we rep... BACKGROUND Low-grade myofibroblastic sarcoma(LGMS)is a rare spindle cell sarcoma espe-cially in the pancreas,with myofibroblastic differentiation.Hitherto,only a few cases have been reported.CASE SUMMARY Herein,we report a case involving the discovery of a pancreatic mass detected during a routine physical examination.Subsequent imaging and pathological tests of the patient led to the diagnosis of LGMS of the pancreas.Following surgical intervention,the patient experienced recurrence and metastasis.Conventional treatment is not effective for postoperative recurrent pancreatic LGMS with multiple metastases.After communicating with the patients and their families,informed consent was obtained for the treatment of anlotinib combined with pembrolizumab.Evaluation of imaging and clinical symptoms post-treatment revealed a relatively favorable response to the combination of anlotinib and pembrolizumab.CONCLUSION Based on the comprehensive literature review,our report aimed to provide evidence for a better understanding of the disease characteristics,diagnostic criteria,imaging findings,and identification of LGMS.And explore novel treatment strategies for this disease. 展开更多
关键词 low-grade myofibroblastic sarcoma PANCREAS Pembrolizumab Anlotinib IMMUNOHISTOCHEMISTRY PATHOLOGY Case report
下载PDF
Low-grade myofibrosarcoma of the maxillary sinus:Two case reports
2
作者 Anna Mydlak ŁukaszŚcibik +4 位作者 Monika Durzynska Jakub Zwoliński Karolina Buchajska Olga Lenartowicz Jakub Kucharz 《World Journal of Clinical Oncology》 2024年第4期566-575,共10页
BACKGROUND Low-grade myofibroblastic sarcoma(LGMS)is an extremely rare tumor characterized by the malignant proliferation of myofibroblasts.LGMS most commonly develops in adults,predominantly in males,in the head and ... BACKGROUND Low-grade myofibroblastic sarcoma(LGMS)is an extremely rare tumor characterized by the malignant proliferation of myofibroblasts.LGMS most commonly develops in adults,predominantly in males,in the head and neck region,oral cavity,especially on the tongue,mandible,and larynx.This article presents 2 cases of LGMS localized to the maxillary sinus and provides an overview of the available literature.CASE SUMMARY Two patients with LGMS located in the maxillary sinus underwent surgery at the Department of Head and Neck Surgery.Case 1:A 46-year-old patient was admitted to the clinic with suspected LGMS recurrence in the right maxillary sinus(rT4aN0M0),with symptoms of pain in the suborbital area,watering of the right eye,thick discharge from the right nostril,and augmented facial asymmetry.After open biopsy-confirmed LGMS,the patient underwent expanded maxillectomy of the right side with immediate palate reconstruction using a microvascular skin flap harvested surgically from the middle arm.The patient qualified for adjuvant radiotherapy for the postoperative bed,with an additional margin.Currently,the patient is under 1.5 years of observation with no evidence of disease.Case 2:A 45-year-old man was admitted to our clinic with facial asymmetry,strabismus,exophthalmos,and visual impairment in the right eye.Six months earlier,the patient had undergone partial jaw resection at another hospital for fibromatosis.A contrast-enhanced computed tomography scan revealed a tumor mass in the postoperative log after an earlier procedure.An open biopsy confirmed lowgrade fibrosarcoma(rT4aN0M0).The patient qualified for an extended total right maxillectomy with orbital excision and right hemimandibulectomy with immediate microvascular reconstruction using an anterolateral thigh flap.The patient subsequently underwent adjuvant radiotherapy to the postoperative area.After 9 months,recurrence occurred in the right mandibular arch below the irradiated area.The lesion infiltrated the base of the skull,which warranted the withdrawal of radiotherapy and salvage surgery.The patient qualified for palliative chemotherapy with a regimen of doxorubicin+dacarbazine+cyclophosphamide and palliative radiotherapy for bone metastases.The patient died 26 months after surgical treatment.The cases have been assessed and compared with cases in the literature.CONCLUSION No specific diagnostic criteria or treatment strategies have been developed for LGMS.The treatment used for LGMS is the same as that used for sinonasal cancer radical tumor excision;adjuvant radiotherapy or chemoradiotherapy should also be considered.They have low malignant potential but are highly invasive,tend to recur,and metastasize to distant sites.Patients should undergo regular follow-up examinations to detect recurrence or metastasis at an early stage.Patients should be treated and observed at the highest referral centers. 展开更多
关键词 Head and neck cancer Paranasal sinuses Maxillary sinus sarcoma low-grade myofibroblastic sarcoma Case report
下载PDF
Low-grade myofibroblastic sarcoma of the palate 被引量:11
3
作者 Tomohiro Yamada Tomohide Yoshimura +3 位作者 Naoya Kitamura Eri Sasabe Seiji Ohno Tetsuya Yamamoto 《International Journal of Oral Science》 SCIE CAS CSCD 2012年第3期170-173,共4页
Low-grade myofibroblastic sarcoma (LGMS) is a rare, malignant tumor with myofibroblastic differentiation. Despite it being classified as a distinct entity by the World Health Organization, a few cases were reported ... Low-grade myofibroblastic sarcoma (LGMS) is a rare, malignant tumor with myofibroblastic differentiation. Despite it being classified as a distinct entity by the World Health Organization, a few cases were reported in the oral and maxillofacial region. Here, a LGMS developed on the palate of a 73-year-old man who presented with a 1-cm tumor on the posterior border of the palate. Based on the histological and immunohistochemical features, a diagnosis of LGMS was established. The tumor was resected, and no recurrence was observed over 2 years. Although the tongue is the most preferred site for LGMS, it may occur in any region of the oral cavity. 展开更多
关键词 low-grade myofibroblastic sarcoma ORAL PALATE
下载PDF
低度恶性肌纤维母细胞肉瘤中NLRP3炎性体的表达 被引量:1
4
作者 张鹏 冯斐斐 +6 位作者 张巧 王家强 高嵩涛 姚伟涛 晋乐飞 王鑫 蔡启卿 《肿瘤防治研究》 CAS CSCD 北大核心 2015年第12期1206-1209,共4页
目的探讨低度恶性肌纤维母细胞肉瘤(low grade myofibroblastic sarcoma,LGMS)组织中NLRP3炎性体蛋白的表达与LGMS发展、转移和预后的关系及其意义。方法采用免疫组织化学法检测13例手术切除的经病理检查确诊的LGMS瘤组织和瘤旁组织中Ca... 目的探讨低度恶性肌纤维母细胞肉瘤(low grade myofibroblastic sarcoma,LGMS)组织中NLRP3炎性体蛋白的表达与LGMS发展、转移和预后的关系及其意义。方法采用免疫组织化学法检测13例手术切除的经病理检查确诊的LGMS瘤组织和瘤旁组织中Caspase-1、ASC和NLRP3蛋白的表达,分析瘤组织中3个NLRP3炎性体蛋白表达与临床病理特征的关系,并采用Pearson相关检验检测3个NLRP3炎性体蛋白两两之间的相关性。结果瘤旁组织中Caspase-1、ASC和NLRP3蛋白表达的平均吸光度值分别为(0.40±0.01)、(0.42±0.01)和(0.37±0.02),均明显高于肌纤维母细胞瘤组织,差异有统计学意义(P<0.05);LGMS转移患者和复发患者瘤组织中Caspase-1、ASC和NLRP3蛋白表达明显低于未发生转移患者和原发肿瘤患者(P<0.05);而瘤组织中NLRP3炎性体蛋白表达与年龄、性别和原发部位是否有慢性炎性反应无关(P>0.05)。两组中Caspase-1、ASC和NLRP3蛋白表达水平两两之间均呈明显正相关(P<0.05)。结论 NLRP3炎性体相关蛋白主要在LGMS瘤旁组织中高表达,且其与LGMS转移与预后有关。 展开更多
关键词 低度恶性肌纤维母细胞肉瘤 炎性体 CASPASE-1 ASC NLRP3
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部